Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FFAR4 | Q5NUL3 | 1/20 | 0.55 |
| ▸ | FFAR1 | O14842 | 1/20 | 0.55 |
| ▸ | PSMD14 | O00487 | 2/20 | 0.53 |
| ▸ | PLA2G1B | P04054 | 2/20 | 0.53 |
| ▸ | MMP2 | P08253 | 2/20 | 0.53 |
| ▸ | ATG4B | Q9Y4P1 | 2/20 | 0.53 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.53 |
| ▸ | RAD52 | P43351 | 1/20 | 0.53 |
| ▸ | GPR84 | Q9NQS5 | 6/20 | 0.52 |
| ▸ | LMNA | P02545 | 4/20 | 0.50 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.48 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.48 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.48 |
| ▸ | MEN1 | O00255 | 1/20 | 0.48 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.48 |
| ▸ | TSHR | P16473 | 1/20 | 0.48 |
| ▸ | CYP2D6 | P10635 | 2/20 | 0.47 |
| ▸ | SPHK1 | Q9NYA1 | 1/20 | 0.47 |
| ▸ | GMNN | O75496 | 1/20 | 0.47 |
| ▸ | POLB | P06746 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9051922 | 1.00 | FFAR4 (0.55) | FFAR4FFAR1PSMD14PLA2G1BMMP2 | |
| SCHEMBL28349975 | 1.00 | FFAR4 (0.55) | FFAR4FFAR1PSMD14PLA2G1BMMP2 | |
| SCHEMBL20896984 | 1.00 | FFAR4 (0.55) | FFAR4FFAR1PSMD14PLA2G1BMMP2 | |
| SCHEMBL995404 | 0.98 | FFAR4 (0.57) | FFAR4FFAR1PSMD14PLA2G1BMMP2 | |
| SCHEMBL21660117 | 0.98 | FFAR4 (0.57) | FFAR4FFAR1PSMD14PLA2G1BMMP2 | |
| SCHEMBL23225808 | 0.98 | FFAR4 (0.57) | FFAR4FFAR1PSMD14PLA2G1BMMP2 | |
| SCHEMBL22910843 | 0.98 | FFAR4 (0.57) | FFAR4FFAR1PSMD14PLA2G1BMMP2 | |
| SCHEMBL4553176 | 0.98 | FFAR4 (0.57) | FFAR4FFAR1PSMD14PLA2G1BMMP2 | |
| SCHEMBL887247 | 0.98 | FFAR4 (0.57) | FFAR4FFAR1PSMD14PLA2G1BMMP2 | |
| SCHEMBL23188459 | 0.98 | FFAR4 (0.57) | FFAR4FFAR1PSMD14PLA2G1BMMP2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 30 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250243143-A1 | 1,3-Fatty Diol Compounds And Derivatives Thereof | AGAIN BIO APS (DK) | 2025-07-31 | — | — | US | claimed |
| US-20250243143-A1 | 1,3-Fatty Diol Compounds And Derivatives Thereof | AGAIN BIO APS (DK) | 2025-07-31 | — | — | US | disclosed |
| US-12304883-B2 | 1,3-fatty diol compounds and derivatives thereof | GENOMATICA, INC. (US) | 2025-05-20 | — | — | US | disclosed |
| CN-114773160-B | 1, 3-Aliphatic diol compound and derivative thereof | 基因组股份公司 | 2025-03-07 | — | — | CN | disclosed |
| EP-4223765-A1 | 1,3-FATTY DIOL COMPOUNDS AND DERIVATIVES THEREOF | Genomatica, Inc. (US) | 2023-08-09 | — | — | EP | disclosed |
| EP-3795576-B1 | 1,3-FATTY DIOL COMPOUNDS AND GLYCOSYLATED DERIVATIVES THEREOF | GENOMATICA INC (US) | 2023-06-07 | — | — | EP | disclosed |
| EP-3795576-B1 | 1,3-FATTY DIOL COMPOUNDS AND GLYCOSYLATED DERIVATIVES THEREOF | GENOMATICA INC (US) | 2023-06-07 | — | — | EP | disclosed |
| CN-114773160-A | 1, 3-aliphatic diol compound and derivative thereof | 基因组股份公司 | 2022-07-22 | — | — | CN | disclosed |
| CN-109890783-B | 1, 3-aliphatic diol compound and derivative thereof | 基因组股份公司 | 2022-06-14 | — | — | CN | disclosed |
| US-20220098133-A1 | 1,3-Fatty Diol Compounds And Derivatives Thereof | AGAIN BIO APS (DK) | 2022-03-31 | — | — | US | disclosed |
| EP-3512825-A1 | 1,3-FATTY DIOL COMPOUNDS AND DERIVATIVES THEREOF | REG Life Sciences, LLC (US) | 2019-07-24 | — | — | EP | disclosed |
| WO-2018053202-A1 | 1,3-FATTY DIOL COMPOUNDS AND DERIVATIVES THEREOF | REG LIFE SCIENCES LLC (US) | 2018-03-22 | — | — | WO | disclosed |
| US-20180072645-A1 | 1,3-FATTY DIOL COMPOUNDS AND DERIVATIVES THEREOF | REG LIFE SCIENCES LLC (US) | 2018-03-15 | — | — | US | disclosed |
| US-20180072645-A1 | 1,3-FATTY DIOL COMPOUNDS AND DERIVATIVES THEREOF | REG LIFE SCIENCES LLC (US) | 2018-03-15 | — | — | US | disclosed |
| US-20180072645-A1 | 1,3-FATTY DIOL COMPOUNDS AND DERIVATIVES THEREOF | REG LIFE SCIENCES LLC (US) | 2018-03-15 | — | — | US | disclosed |
| WO-1996036683-A1 | MIXED PHOSPHOROUS- AND SULFUR-CONTAINING REACTION PRODUCTS USEFUL IN POWER TRANSMITTING COMPOSITIONS | EXXON CHEMICAL PATENTS INC. (US) | 1996-11-21 | — | — | WO | disclosed |
| US-5534170-A | OXIDATION AND WEAR RESISTANCE; BETA-HYDROXY THIOETHER, ORGANOPHOSPHITE, AND HYDROXY NUCLEOPHILIC REACTANTS | EXXON CHEMICAL PATENTS INC. (US) | 1996-07-09 | — | — | US | disclosed |
| US-5326487-A | Mixed phosphorous- and sulfur- containing reaction products useful in power transmitting compositions | EXXON CHEMICAL PATENTS INC. (US) | 1994-07-05 | — | — | US | disclosed |
| EP-0394381-B1 | MIXED PHOSPHOROUS- AND SULFUR-CONTAINING REACTION PRODUCTS USEFUL IN POWER TRANSMITTING COMPOSITIONS | EXXON CHEMICAL PATENTS INC (US) | 1994-05-04 | — | — | EP | disclosed |
| US-5242612-A | A mixture of phosphorus- and nonphosphorus products resulting from the reaction of a beta-hydroxy thioether and an organic phosphite; power transmission fluids; crankcase oils; oxidation, wear and friction resistance | EXXON CHEMICAL PATENTS INC. (US) | 1993-09-07 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250243143-A1 | 1,3-Fatty Diol Compounds And Derivatives Thereof | DGAT1, DGAT2, DSG1 | FFAR4 287/4885FFAR1 115/4885PSMD14 1199/4885 |
| US-20180072645-A1 | 1,3-FATTY DIOL COMPOUNDS AND DERIVATIVES THEREOF | DGAT1, DGAT2, DSG1 | FFAR4 287/4885FFAR1 115/4885PSMD14 1199/4885 |
| US-12304883-B2 | 1,3-fatty diol compounds and derivatives thereof | DGAT1, DGAT2, DSG1 | FFAR4 287/4885FFAR1 115/4885PSMD14 1199/4885 |
| US-20220098133-A1 | 1,3-Fatty Diol Compounds And Derivatives Thereof | DGAT1, DGAT2, DSG1 | FFAR4 287/4885FFAR1 115/4885PSMD14 1199/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.